Biochemical and Immunological Properties of Engineered Low-Immunogenic Staphylokinases for Next-Generation Thrombolytic TherapyAlan Strunga, Jiřı́ Damborský, Lukáš Kubala et al.|bioRxiv (Cold Spring Harbor Laboratory)|2026Cited by 0